MIRA INFORM REPORT

 

 

Report No. :

306866

Report Date :

09.02.2015

 

IDENTIFICATION DETAILS

 

Name :

ARKRAY INC

 

 

Registered Office :

Kyoto Miyuki Bldg 10F, 689 Takanacho Karasumadori-4jo-Iru Nakagyoku Kyoto

604--8153

 

 

Country :

Japan

 

 

Date of Incorporation :

Sept., 1967

 

 

Com. Reg. No.:

1300-01-009892 (Kyoto-Nakagyoku)

 

 

Legal Form :

Limited Company (Kabushiki Kaisha)

 

 

Line of Business :

Import, Wholesale of Medical Instruments.

 

 

No. of Employees :

15/20

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

 

Status :

Moderate

 

 

Payment Behaviour :

Unknown

 

 

Litigation :

Clear

 

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – December 31, 2014

 

Country Name

Previous Rating

(30.09.2014)

Current Rating

(31.12.2014)

Japan

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

 

 


 

JAPAN - ECONOMIC OVERVIEW

 

In the years following World War II, government-industry cooperation, a strong work ethic, mastery of high technology, and a comparatively small defense allocation (1% of GDP) helped Japan develop a technologically advanced economy. Two notable characteristics of the post-war economy were the close interlocking structures of manufacturers, suppliers, and distributors, known as keiretsu, and the guarantee of lifetime employment for a substantial portion of the urban labor force. Both features are now eroding under the dual pressures of global competition and domestic demographic change. Japan's industrial sector is heavily dependent on imported raw materials and fuels. A small agricultural sector is highly subsidized and protected, with crop yields among the highest in the world. While self-sufficient in rice production, Japan imports about 60% of its food on a caloric basis. For three decades, overall real economic growth had been spectacular - a 10% average in the 1960s, a 5% average in the 1970s, and a 4% average in the 1980s. Growth slowed markedly in the 1990s, averaging just 1.7%, largely because of the after effects of inefficient investment and an asset price bubble in the late 1980s that required a protracted period of time for firms to reduce excess debt, capital, and labor. Modest economic growth continued after 2000, but the economy has fallen into recession three times since 2008. A sharp downturn in business investment and global demand for Japan's exports in late 2008 pushed Japan into recession. Government stimulus spending helped the economy recover in late 2009 and 2010, but the economy contracted again in 2011 as the massive 9.0 magnitude earthquake and the ensuing tsunami in March disrupted manufacturing. The economy has largely recovered in the two years since the disaster, but reconstruction in the Tohoku region has been uneven. Prime Minister Shinzo ABE has declared the economy his government's top priority; he has overturned his predecessor's plan to permanently close nuclear power plants and is pursuing an economic revitalization agenda of fiscal stimulus, monetary easing, and structural reform. Japan joined the Trans Pacific Partnership negotiations in 2013, a pact that would open Japan's economy to increased foreign competition and create new export opportunities for Japanese businesses. Measured on a purchasing power parity (PPP) basis that adjusts for price differences, Japan in 2013 stood as the fourth-largest economy in the world after second-place China, which surpassed Japan in 2001, and third-place India, which edged out Japan in 2012. The new government will continue a longstanding debate on restructuring the economy and reining in Japan's huge government debt, which is exceeding 230% of GDP. To help raise government revenue and reduce public debt, Japan decided in 2013 to gradually increase the consumption tax to a total of 10% by the year 2015. Japan is making progress on ending deflation due to a weaker yen and higher energy costs, but reliance on exports to drive growth and an aging, shrinking population pose other major long-term challenges for the economy.

 

Source : CIA

 

 

 

 


NOTE

 

In absence of financials, no credit limit could be recommended.

 

 

Company Name and address

 

ARKRAY INC

 

REGD NAME:    Arkray KK

 

MAIN OFFICE:  Kyoto Miyuki Bldg 10F, 689 Takanacho Karasumadori-4jo-Iru Nakagyoku Kyoto

          604--8153 JAPAN

                                    Tel: 050-5527-9301     

 

URL:                 http://www.arkrayco.jp

E-Mail address:            (thru the URL)

 

 

ACTIVITIES

 

Import, wholesale of medical instruments

 

 

BRANCHES

 

Nil

 

 

OFFICERS

 

TAKESHI MATSUDA, PRES      

           

Yen Amount:     In million Yen, unless otherwise stated

 

 

SUMMARY

 

FINANCES        UNDETD           A/SALES                      Yen NOT DISCLOSED

PAYMENTSREGULAR   CAPITAL                       Yen 99 M

TREND UNDETD           WORTH                        Yen NOT DISCLOSED

STARTED         1967                 EMPLOYES                  15/20

 

 

COMMENT    

 

TRADING FIRM SPECIALIZINF IN MEDICAL INSTRUMENTS.

 

FINANCIAL SITUATION CONSIDERED UNDETERMINED DUE TO THE LACK OF PROVEN BUSINESS.

                       

MAX CREDIT LIMIT: UNABLE TO BE ASSESSED DUE TO THE SAME REASON.

 

 

HIGHLIGHTS

           

The subject company was established by Tadashi Doi in order to make the most of his experience and has been succeeded by the present executives.  This is a trading firm for import and wholesale of medical instruments, reagents: such as test for diabetes, test for urine, health care, beauty care products, other. 

 

 

FINANCIAL INFORMATION

           

Financials are not disclosed. The only financials disclosed are old for Oct/2007 fiscal term, wherein the firm said: sales Yen 37,420 million, net profit Yen 782 million, total assets Yen 36,800 million, net worth Yen 30,904 million.

 

Both the financial situation and business trends are not determined due to the lack of proven business, which the firm does not release.

 

 

REGISTRATION

 

Date Registered:                      Sept 1967

Regd No.:                                 1300-01-009892 (Kyoto-Nakagyoku)

Legal Status:               Limited Company (Kabushiki Kaisha)

Authorized:                  792,000 shares

Issued:                         198,000 shares

Sum:                            Yen 99 million

Major shareholders (%): Takeshi Matsuda and Doi families (--100%)

No. of shareholders: 7

 

Nothing detrimental is known as to the commercial morality of executives.

 

 

OPERATION

           

Activities: Import and wholesales medical instruments for testing diabetes, urine, other, health care products, beauty care and foot care products (--100%)

 

Clients: [Mfrs, wholesalers] Arkray Global Business (55%), Arkray Marketing (45%), other

No. of accounts: limited

Domestic areas of activities: Centered in greater-Osaka & Kyoto

 

Suppliers: [Mfrs, wholesalers] Panasonic Healthcare, Sekisui Chemical Ind, MC laboratories, other

 

Payment record: Unknown 

 

Location: Business area in Kyoto.  Office premises at the caption address are leased and maintained satisfactorily.

 

Bank References:

            Kyoto Bank (Inari)

            MUFG (Kyoto-Chuo)

            Relations: Satisfactory

 

 

FINANCES

(In Million Yen)

 

NOT DISCLOSED AND UNAVALABLE

 

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.61.74

UK Pound

1

Rs.94.65

Euro

1

Rs.70.79

 

INFORMATION DETAILS

 

Analysis Done by :

DIV

 

 

Report Prepared by :

NIT

 

               

RATING EXPLANATIONS

 

RATING

STATUS

PROPOSED CREDIT LINE

 

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

 

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

 

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

 

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

 

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

 

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

 

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

Credit not recommended

 

--

NB

New Business

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.